Drug evaluation: FavId, a patient-specific idiotypic vaccine for non-Hodgkin's lymphoma
Reinis, M.
Current Opinion in Molecular Therapeutics 9(3): 291-298
2007
ISSN/ISBN: 1464-8431 PMID: 17608028 Document Number: 609754
Favrille Inc is developing FavIld, a patient-specific immunotherapy combining tumor-specific idiotype protein and keyhole limpet hemocyanin, for the potential treatment of lymphoma. A phase III clinical trial in follicular B-cell non-Hodgkin's lymphoma is underway.
Document emailed within 1 workday
Related Documents
Montalban, C.; Bellas, C.; Rodriguez-Garcia, J.L.; Aguado, M.; Fernandez-Muñoz, R. 1991: Non-Hodgkin's lymphoma after prolonged remission of Hodgkin's disease in an HIV-infected patient Annals of Oncology: Official Journal of the European Society for Medical Oncology 2(8): 585-587Bucerius, J.; Herkel, C.; Joe, A.Y.; Altehoefer, C.; Finke, J.; Moser, E.; Reinhardt, M.J. 2006: (18)F-FDG PET and conventional imaging for assessment of Hodgkin's disease and non Hodgkin's lymphoma. An analysis of 193 patient studies Nuklearmedizin. Nuclear medicine 45(3): 105-10; quiz N25-6
Stolzenbach, G.; Garbrecht, M.; Müllerleile, U. 1978: Intermittent chlorambucil-prednisone therapy in low malignancy non-Hodgkin lymphoma and cyclic induction chemotherapy with COP-bleomycin of severe non-Hodgkin lymphoma according to the Kiel classification Verhandlungen der Deutschen Gesellschaft für Innere Medizin 84: 177-180
Jarrett, R.F.; Gledhill, S.; Qureshi, F.; Crae, S.H.; Madhok, R.; Brown, I.; Evans, I.; Krajewski, A.; O'Brien, C.J.; Cartwright, R.A. 1988: Identification of human herpesvirus 6-specific DNA sequences in two patients with non-Hodgkin's lymphoma Leukemia 2(8): 496-502
Somoza, N.; Morgenfeld, M.C.; Magnasco, J.; Pavlovsky, S.; Cavagnaro, F.J.; Saslavsky, J.; de Maria, H.; Macchi, A.; Suárez, A. 1978: Comparative study of two drug combination in non-Hodgkin's lymphoma Sangre 23(4): 418-425
Darmawan, G.; Wijaya, I.; Hamijoyo, L.; Fadjari, T.H. 2017: Paraneoplastic Arthritis in a Patient with Non-Hodgkin's Lymphoma Acta Medica Indonesiana 49(3): 267-269
Gobbi, M.; Pileri, S.; Testoni, N.; Mazza, P.; Dinota, A.; Tura, S. 1989: New directions in the prognostic evaluation of non-Hodgkin's lymphoma Haematologica 74(5 Suppl): 392-402
Van Melick, E.J.; Haak, H.L.; te Velde, J. 1988: A patient with acute non-lymphatic leukemia 2 years after non-Hodgkin lymphoma Nederlands Tijdschrift Voor Geneeskunde 132(15): 684-687
Guarner, J.; Austin, G.E.; Nassar, V.H.; Sarma, P.R.; Boedecker, E. 1986: Biclonal gammopathy (IgG kappa and IgG lambda) in a patient with non-Hodgkin's lymphoma Archives of Pathology and Laboratory Medicine 110(5): 445-448
Giménez-Mesa, E.; Martínez-Salio, A.; Porta-Etessam, J.; Berbel García, A.; Cedena Romero, T.; Salama Bendoyan, P. 2001: Reversible posterior leukoencephalopathy in a patient with non-Hodgkin's lymphoma after treatment with CHOP Anales de Medicina Interna 18(11): 591-593
Morales, E.; Bancalari, G.; Fahrenkrog, A.M.; Rossle, A. 1999: Chronic myeloid leukemia and non Hodgkin lymphoma in the same patient. Clinical case Revista Medica de Chile 127(9): 1105-1107
García Gala, J.M.; Ramírez Páyer, A.; Rayón, C.; Rodríguez Vicente, P.; Rosón, C.; Blanco, C. 1993: Chronic posttransfusion graft-vs-host disease in a patient with non-Hodgkin's lymphoma Sangre 38(6): 489-491
Colburn, K.K.; Cao, J.D.; Krick, E.H.; Mortensen, S.E.; Wong, L.G. 1985: Hodgkin's lymphoma in a patient treated for Wegener's granulomatosis with cyclophosphamide and azathioprine Journal of Rheumatology 12(3): 599-602
van der Heijden, R.W.; Bunschoten, H.; Pascual, V.; Uytdehaag, F.G.; Osterhaus, D.M.; Capra, J.D. 1990: Nucleotide sequence of a human monoclonal anti-idiotypic antibody specific for a rabies virus-neutralizing monoclonal idiotypic antibody reveals extensive somatic variability suggestive of an antigen-driven immune response Journal of Immunology 144(7): 2835-2839
Morikov, D.D.; Morikova, E.G.; Dvornichenko, V.V. 2015: Pharmacoeconomic Analysis of the use of Hepatoprotectors in Management of Drug-Associated Liver Injury Due to Hodgkin's Lymphoma Chemotherapy Antibiotiki i Khimioterapiia 60(7-8): 23-26
Georgiadi, E.C.; Sachinis, N.; Dimtsas, G.; Vassilakopoulos, T.P.; Kittas, C.; Doussis-Anagnostopoulou, I.A. 2012: Evaluation of apoptosis in classical Hodgkin's lymphoma comparing different methods Journal of BUON: Official Journal of the Balkan Union of Oncology 17(4): 746-752
Sharkunov, N.N.; Moiseyeva, T.N.; Zybunova, E.E.; Vinogradova, O.Y.; Kravchenko, S.K. 2012: Successful treatment for Hodgkin's lymphoma in a female patient with Ph+ chronic myeloid leukemia Terapevticheskii Arkhiv 84(11): 71-74
Mohan, J.C.; Khan, J.A.; Srivastava, S.; Malik, V.K. 1993: Non-Hodgkin's lymphoma presenting as restrictive cardiomyopathy in a patient with two previously unrelated malignancies Indian Heart Journal 45(6): 497-499
Albano, D.; Sinagra, E.; Patti, C.; Narese, D.; Agrusa, A.; Di Buono, G.; Raimondo, D.; Midiri, M.; Lagalla, R.; Galia, M. 2017: Caecal leiomyoma detected by whole-body MRI in a patient with Hodgkin lymphoma: first case report Il Giornale di Chirurgia 38(1): 27-32
Verani, D.A. 1991: Association of non-Hodgkin's lymphoma and Kaposi's sarcoma in a patient with HIV infection: case report Bollettino dell'Istituto Sieroterapico Milanese 70(1-2): 453-455